GET DAILY SIGNALSIBM (IBM): Assessing the Path to a $275 Price Target
Key Takeaways
- The central stock price target used here is $275, roughly 12% above IBM's latest verified closing price near $245.
- This $275 level is the average of verified analyst price targets above the current price, rather than a simple consensus, because the overall mean of all targets sits too close to the market price.
- The overall mean of all tracked targets is roughly $259 to $266, with individual targets spanning a wide range from about $174 to $300 (one data provider shows a lone $350 outlier).
- Supporting factors include accelerating software growth, a recovering consulting segment, expanding margins, and new AI and quantum-computing initiatives.
- The biggest risks are lingering consulting weakness, dependence on the mainframe cycle, intense AI competition, and an elevated valuation relative to historical norms.
- Readers can explore the company's Major News, Today's Price Move, Forecast, and Earnings on dedicated pages for deeper, continuously updated detail.
- For automated market insight, explore Trending AI Robots, which track real-time signals across thousands of tickers.
Analyst Price Targets and Consensus View
IBM carries broad but divided analyst coverage. Data providers tracking roughly 25 to 34 individual targets report an overall average analyst price target near $260 — approximately $259 to $266 depending on the source — with a low-to-high range of about $174 to $300. Because that overall mean implies only about 6% to 8% upside from the latest price, it falls short of the 10% threshold used for this analysis. As a result, the central $275 target is calculated as the average of the verified targets above the current price. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
That above-price cluster is anchored by a number of recent updates. Evercore ISI reiterated an Outperform rating and a $275 target in early November 2026, describing a sum-of-the-parts value near $290. Following third-quarter results, BMO Capital raised its target to $265, Truist Securities to $260, and Stifel to $260, citing strength in mainframe software and infrastructure; UBS lifted its target to $243 on mixed but better-than-expected results. The spread between cautious targets near $240 and bullish targets near $300 reflects genuine disagreement over how much of IBM's AI and software transition is already priced in.
Current Market Position and Path Toward the Target
IBM's latest verified closing price is about $245, with a market capitalization near $232 billion and a price-to-earnings (P/E) ratio around 20. Reaching $275 would require a rise of roughly 12%, a substantial move. The shares are down roughly 26% from a 52-week high near $332 and remain below the levels of a year ago, even after a solid earnings report.
The path toward $275 would likely depend on sustained double-digit software growth, further consulting recovery, and continued gross- and pre-tax margin expansion as software becomes a larger share of revenue. IBM's third-quarter 2026 results showed revenue near $17.1 billion (up roughly 5% year over year) and earnings per share (EPS) near $2.30 (up roughly 25%), suggesting improving profitability even with modest top-line growth.
What Could Support a Move Toward the Target
Several verified factors could support a move higher. IBM's software business, including Red Hat and HashiCorp, has been growing at double-digit rates, and its automation portfolio is strengthening. Consulting has inflected back to growth, and AI-related work — building and managing enterprise AI applications, plus new AI-governance and security tools — is adding incremental revenue. The company has also advanced its quantum-computing roadmap, including a Quantum System Two deployment in Chicago and a quantum error-correction partnership with AMD and Oak Ridge National Laboratory. A shift toward higher-margin software supports the margin-expansion thesis that underpins many bullish targets.
What Could Prevent the Target From Being Reached
The principal risks are equally concrete. Consulting remains a mixed business, and any renewed slowdown would pressure the growth narrative. A meaningful portion of infrastructure revenue is tied to the mainframe cycle, which is inherently lumpy. IBM also competes against well-funded rivals in cloud and AI, and its valuation, while not extreme, is elevated relative to its slower historical growth. If software growth decelerates, margins stall, or investors rotate away from AI-adjacent names, the stock could struggle to re-rate toward $275.
Technical Levels and Market Structure
Technically, the shares have been consolidating above a support level near $240–$245, close to the 20-day moving average, with deeper support near the 60-day average around $236 and the 52-week low near $199. The resistance level to watch sits between $275 and $300, a zone that coincides with the bullish end of the analyst range; above that, the prior 52-week high near $332 marks the next major obstacle. From what I see, these levels align closely with the analyst range and warrant close attention.
Time Horizon and What Investors Should Monitor
Analyst targets generally reflect a research horizon of about 12 months, though individual firms rarely publish identical timeframes. Investors should monitor the next quarterly report, management guidance on software and consulting, any further analyst target revisions, and broader market sentiment toward AI and enterprise-technology names. Rate decisions and macroeconomic data can also affect how richly the market is willing to value a stock with IBM's growth profile.
Using AI Daily Buy/Sell Signals
In my own work, I often rely on Tickeron’s AI Daily Buy/Sell Signals to supplement traditional analysis. The platform applies artificial intelligence to scan thousands of stocks and ETFs in real time, delivering Buy, Sell, or Hold signals based on technical behavior and market shifts. It helps surface opportunities and track trends more efficiently, serving as a practical complement when evaluating names like IBM.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
IBM in upward trend: 10-day moving average moved above 50-day moving average on October 21, 2026
The 10-day moving average for IBM crossed bullishly above the 50-day moving average on October 21, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 71%.
Technical Analysis (Indicators)
Bullish Trend Analysis
IBM moved above its 50-day moving average on October 15, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +3.21% 3-day Advance, the price is estimated to grow further. Considering data from situations where IBM advanced for three days, in 248 of 375 cases, the price rose further within the following month. The odds of a continued upward trend are 66%.
The Aroon Indicator entered an Uptrend today. In 166 of 271 cases where IBM Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 61%.
Bearish Trend Analysis
The 10-day RSI Indicator for IBM moved out of overbought territory on November 02, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 47 similar instances where the indicator moved out of overbought territory. In 24 of the 47 cases, the stock moved lower in the following days. This puts the odds of a move lower at 51%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 31 of 55 cases where IBM's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 56%.
The Momentum Indicator moved below the 0 level on November 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on IBM as a result. In 50 of 81 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 62%.
The Moving Average Convergence Divergence Histogram (MACD) for IBM turned negative on November 06, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 38 similar instances when the indicator turned negative. In 27 of the 38 cases the stock turned lower in the days that followed. This puts the odds of success at 71%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IBM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 53%.
IBM broke above its upper Bollinger Band on October 20, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron SMR rating for this company is 29 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 40 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock slightly better than average.
The Tickeron Price Growth Rating for this company is 46 (best 1 - 100 worst), indicating steady price growth. IBM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 76 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.700) is normal, around the industry mean (2.898). P/E Ratio (21.379) is within average values for comparable stocks, (18.492). Projected Growth (PEG Ratio) (2.087) is also within normal values, averaging (2.284). Dividend Yield (0.028) settles around the average of (0.224) among similar stocks. P/S Ratio (3.271) is also within normal values, averaging (139.965).
The Tickeron PE Growth Rating for this company is 87 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a manufacturer of various computer products through the use of advanced information technology
Industry InformationTechnologyServices
Advertisement